Analysis of public datasets (GSE5820) revealed that TET1 expression is elevated in patients with T-cell acute lymphoblastic leukemia (T-ALL) and serves as a biomarker for decreased survival. This evidence concerns the gene TET1 and acute lymphoblastic leukemia.